DRIZALMA Drug Patent Profile
✉ Email this page to a colleague
When do Drizalma patents expire, and what generic alternatives are available?
Drizalma is a drug marketed by Sun Pharm and is included in one NDA. There are five patents protecting this drug.
The generic ingredient in DRIZALMA is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Drizalma
A generic version of DRIZALMA was approved as duloxetine hydrochloride by AUROBINDO PHARMA LTD on December 11th, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DRIZALMA?
- What are the global sales for DRIZALMA?
- What is Average Wholesale Price for DRIZALMA?
Summary for DRIZALMA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for DRIZALMA |
| DailyMed Link: | DRIZALMA at DailyMed |
US Patents and Regulatory Information for DRIZALMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-001 | Jul 19, 2019 | RX | Yes | No | 9,839,626 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-004 | Jul 19, 2019 | RX | Yes | Yes | 10,413,525 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-002 | Jul 19, 2019 | RX | Yes | No | 10,413,525 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-001 | Jul 19, 2019 | RX | Yes | No | 11,202,772 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-003 | Jul 19, 2019 | RX | Yes | No | 9,839,626 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-004 | Jul 19, 2019 | RX | Yes | Yes | 12,171,742 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sun Pharm | DRIZALMA SPRINKLE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516-002 | Jul 19, 2019 | RX | Yes | No | 9,839,626 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
